Lamivudine therapy for a hepatitis B surface antigen (HBsAg)-positive leukemia patient receiving myeloablative chemotherapy and autologous stem cell transplantation

[1]  Ally,et al.  A ONE-YEAR TRIAL OF LAMIVUDINE FOR CHRONIC HEPATITIS B , 2000 .

[2]  E. Schiff,et al.  Lamivudine as initial treatment for chronic hepatitis B in the United States. , 1999, The New England journal of medicine.

[3]  C. Chu,et al.  Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy , 1999, Hepatology.

[4]  M. Picardi,et al.  Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation , 1998, Bone Marrow Transplantation.

[5]  B. Chapman,et al.  Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  K. Akashi,et al.  Autologous peripheral blood stem cell transplantation for acute myelogenous leukemia , 1997, Bone Marrow Transplantation.

[7]  R. Liang,et al.  Hepatic events after bone marrow transplantation in patients with hepatitis B infection: a case controlled study , 1997, Bone Marrow Transplantation.

[8]  R. Schinazi,et al.  Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Urdea,et al.  Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. , 1991, Nucleic acids symposium series.

[10]  R. Perrillo.  Treatment of Chronic Hepatitis B with Interferon: Experience in Western Countries , 1989, Seminars in liver disease.

[11]  L Davies,et al.  Bone marrow transplant. , 1985, Nursing times.